Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Alpert

Showing results (31-40 of 1,043) with videos related to

Pageof 105
Sort By:
The American Journal of Medicine|February 8, 2005
Doctors and the drug industry: how can we handle potential conflicts of interest?Joseph S Alpert
Current Cardiology Reports|October 16, 2004
Restenosis following percutaneous coronary arterial intervention: what should the clinician do in order to identify and treat this complication?Joseph S Alpert
The American Journal of Medicine|September 2, 2006
What diet should we recommend to patients?Joseph S Alpert
Current Cardiology Reports|May 4, 2005
Atrial fibrillation: now one of the most common causes for hospitalizationJoseph S Alpert
The American Journal of Medicine|June 1, 2005
Viagra: the risks of recreational useJoseph S Alpert
The American Journal of Cardiology|December 5, 1991
Importance of the pharmacological profile of thrombolytic agents in clinical practiceJ S Alpert
The American Journal of Medicine|July 11, 2006
A universal language of the heartJoseph S Alpert
The American Journal of Medicine|November 22, 2019
Bleeding Risk in Elderly Patients Receiving Anticoagulant Therapy: Should Dosage Be Reduced?Joseph S Alpert
The American Journal of Medicine|July 24, 2021
Recent Thoughts Concerning Atrial FibrillationJoseph S Alpert
The American Journal of Medicine|May 21, 2013
Marijuana for diabetic controlJoseph S Alpert
Pageof 105

Showing results (31-40 of 1,043) with videos related to

Sort By:
Pageof 105
The American Journal of Medicine|February 8, 2005
Doctors and the drug industry: how can we handle potential conflicts of interest?Joseph S Alpert
Current Cardiology Reports|October 16, 2004
Restenosis following percutaneous coronary arterial intervention: what should the clinician do in order to identify and treat this complication?Joseph S Alpert
The American Journal of Medicine|September 2, 2006
What diet should we recommend to patients?Joseph S Alpert
Current Cardiology Reports|May 4, 2005
Atrial fibrillation: now one of the most common causes for hospitalizationJoseph S Alpert
The American Journal of Medicine|June 1, 2005
Viagra: the risks of recreational useJoseph S Alpert
The American Journal of Cardiology|December 5, 1991
Importance of the pharmacological profile of thrombolytic agents in clinical practiceJ S Alpert
The American Journal of Medicine|July 11, 2006
A universal language of the heartJoseph S Alpert
The American Journal of Medicine|November 22, 2019
Bleeding Risk in Elderly Patients Receiving Anticoagulant Therapy: Should Dosage Be Reduced?Joseph S Alpert
The American Journal of Medicine|July 24, 2021
Recent Thoughts Concerning Atrial FibrillationJoseph S Alpert
The American Journal of Medicine|May 21, 2013
Marijuana for diabetic controlJoseph S Alpert
Pageof 105